Eligibility of real-world patients with metastatic breast cancer for clinical trials

INTRODUCTION: The results of clinical trials in metastatic breast cancer (MBC) are generalized to real-world patients. This study determines the proportion of real-world patients who would be eligible for clinical trials and compares outcomes in eligible versus ineligible patients. METHODS: Patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Batra, Atul, Kong, Shiying, Cheung, Winson Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586241/
https://www.ncbi.nlm.nih.gov/pubmed/33120082
http://dx.doi.org/10.1016/j.breast.2020.10.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586241/
https://www.ncbi.nlm.nih.gov/pubmed/33120082
http://dx.doi.org/10.1016/j.breast.2020.10.005

Ejemplares similares